Home » Topics » BioWorld

BioWorld
RSS

DOW EXTENDS AGREEMENT WITH GENSIA

Oct. 11, 1991

XOMA/CENTOCOR TRIAL WINDING DOWN

Oct. 11, 1991

IMMUNOLOGY, BAXTER FINALIZE MAJOR DEAL

Oct. 11, 1991

RAT MODEL FOR TYPE 2 DIABETES

Oct. 11, 1991

STEALTH DELIVERY FOR TAXOL

Oct. 11, 1991

IMMUNEX'S MARKET SHARE DISPUTED

Oct. 11, 1991

CONGRESSMAN BLASTS AMGEN PROFITS

Oct. 11, 1991

ANERGEN RAISES $14 MILLION IN IPO

Oct. 11, 1991

ALKERMES FILES FOR SECONDARY OFFERING

Oct. 11, 1991

AMEX TO TRADE SIX BIOTECH STOCKS

Oct. 10, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...